June 28, 2017
Cell Medica to Manufacture WT1-TCR Therapy for Mesothelioma, Other Solid Tumors in 2018
News
Cell Medica will begin manufacturing WT1-TCR cell therapy for solid tumors that have been difficult to treat with conventional therapies, such ... Read more
June 27, 2017June 27, 2017
Assessing Chemo and Immunotherapy Biomarkers at the Right Time Seen as Crucial in Mesotheliomia Monitoring
News
The point at which doctors assess biomarkers of mesothelioma patients’ response to a combination of chemotherapy and immunotherapy ... Read more
June 26, 2017June 26, 2017
Mesothelioma Risk Continues to Increase — 40 Years After Exposure
News
Even though 40 years have passed since their exposure to asbestos, workers’ risk of developing mesothelioma continues to rise, new research shows. Individuals ... Read more
June 23, 2017
Researchers Identify CXCR4 as Weak Therapeutic Target for Pleural Mesothelioma
News
A new study reports that a protein formerly identified as a potential therapeutic target in pleural mesothelioma, CXCR4, might not ... Read more
June 22, 2017
PD-L1-positive Immune Cells May Help to Predict Survival Rates in EPMM, Study Says
News
A study that looked into France’s RENAPE Observational Registry, a database of rare peritoneal tumors, found that the presence ... Read more
June 21, 2017
Combining Immunotherapy, Accelerated Radiation and Surgery Bolsters Immune Response Against Mesothelioma, Study Shows
News
Combining immunotherapy, accelerated radiation and surgery can improve immune system response against malignant pleural mesothelioma, according to a study. Immunotherapies ... Read more
June 20, 2017
New Way to Promote Cell Death Could Lead to Better Mesothelioma Therapies, Study Reports
News
Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. ... Read more
June 19, 2017June 19, 2017
Zoledronic Acid Could Be a Mesothelioma Add-On Treatment, Researchers Contend After Pilot Study
News
Zoledronic acid was only modestly active as a stand-alone therapy for advanced malignant pleural mesothelioma in a small Phase ... Read more
June 16, 2017
TCR²’s Engineered Immune T-Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show
News
A key approach to treating cancer these days is engineering immune T-cells to produce receptors on their surfaces that ... Read more
June 15, 2017June 15, 2017
Chemotherapy Effective in Peritoneal Mesothelioma, But Surgery Also Needs Evaluation, Researchers Say
News
Aggressive malignant peritoneal mesothelioma responds to treatment with Alimta (pemetrexed) and Platinol (cisplatin) chemotherapy, reports a study examining patient ... Read more
June 14, 2017June 14, 2017
MicroRNAs Help Predict Pleural Mesothelioma Outcomes, European Study Finds
News
European researchers have identified two microRNAs, or small non-coding RNA molecules, that can be used to predict outcomes of malignant pleural ... Read more
June 13, 2017June 13, 2017
Prestigious Publication Highlights 2016 Scientific Advances in Thoracic Oncology
News
Last year’s progress in preventing, diagnosing and treating all forms of lung cancer, including mesothelioma, is summarized in the second ... Read more

Cell Medica to Manufacture WT1-TCR Therapy for Mesothelioma, Other Solid Tumors in 2018

Cell Medica will begin manufacturing WT1-TCR cell therapy for solid tumors that have been difficult to treat with conventional therapies, such as mesothelioma and ovarian cancer. Cell Medica is planning to ... Read more

June 27, 2017June 27, 2017

Assessing Chemo and Immunotherapy Biomarkers at the Right Time Seen as Crucial in Mesotheliomia Monitoring

News

The point at which doctors assess biomarkers of mesothelioma patients’ response to a combination of chemotherapy and immunotherapy is crucial to obtaining a clear picture of how the patients are ... Read more

June 26, 2017June 26, 2017

Mesothelioma Risk Continues to Increase — 40 Years After Exposure

News

Even though 40 years have passed since their exposure to asbestos, workers’ risk of developing mesothelioma continues to rise, new research shows. Individuals exposed to asbestos four decades ago are nearly three times ... Read more

June 23, 2017

Researchers Identify CXCR4 as Weak Therapeutic Target for Pleural Mesothelioma

News

A new study reports that a protein formerly identified as a potential therapeutic target in pleural mesothelioma, CXCR4, might not be a relevant approach for the treatment of such patients. ... Read more

June 22, 2017

PD-L1-positive Immune Cells May Help to Predict Survival Rates in EPMM, Study Says

News

A study that looked into France’s RENAPE Observational Registry, a database of rare peritoneal tumors, found that the presence of programmed death-ligand 1 (PD-L1) on immune cells in epithelioid ... Read more

June 21, 2017

Combining Immunotherapy, Accelerated Radiation and Surgery Bolsters Immune Response Against Mesothelioma, Study Shows

News

Combining immunotherapy, accelerated radiation and surgery can improve immune system response against malignant pleural mesothelioma, according to a study. Immunotherapies for solid tumors have become a major focus of cancer ... Read more

June 20, 2017

New Way to Promote Cell Death Could Lead to Better Mesothelioma Therapies, Study Reports

News

Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. The research, ”Connexin 43 enhances Bax activation via JNK activation ... Read more

June 19, 2017June 19, 2017

Zoledronic Acid Could Be a Mesothelioma Add-On Treatment, Researchers Contend After Pilot Study

News

Zoledronic acid was only modestly active as a stand-alone therapy for advanced malignant pleural mesothelioma in a small Phase 2 pilot clinical trial. But researchers argue that its properties ... Read more

June 16, 2017

TCR²’s Engineered Immune T-Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show

News

A key approach to treating cancer these days is engineering immune T-cells to produce receptors on their surfaces that recognize cancer, so that the T-cells can attack it. One ... Read more

June 15, 2017June 15, 2017

Chemotherapy Effective in Peritoneal Mesothelioma, But Surgery Also Needs Evaluation, Researchers Say

News

Aggressive malignant peritoneal mesothelioma responds to treatment with Alimta (pemetrexed) and Platinol (cisplatin) chemotherapy, reports a study examining patient outcomes. But more studies are needed to compare chemo’s effectiveness to ... Read more